Cullinan Therapeutics, Inc. · NASDAQ:CGEM
Cullinan Therapeutics, Inc. shareholders
As of Jun 30, 2026, 175 institutions reported holding Cullinan Therapeutics, Inc. Largest: Mpm Bioimpact LLC, Lynx1 Capital Management LP and Bvf Inc. New holders, exits, insiders and big stakes, each with its filing.
| Holder | Shares | % of Cullinan Therapeutics, Inc. | Change | Filed |
|---|---|---|---|---|
| Mpm Bioimpact LLC | 9.73M | +2.08M | Aug 14, 2026 | |
| Lynx1 Capital Management LP | 8.96M | no change | Aug 13, 2026 | |
| Bvf Inc | 5.75M | no change | Aug 14, 2026 | |
| BlackRock | 5.23M | +783K | Aug 7, 2026 | |
| T. Rowe Price | 3.83M | +1.8M | Aug 14, 2026 | |
| Vanguard | 3.79M | +359K | Aug 13, 2026 | |
| State Street | 3.67M | +1.12M | Aug 7, 2026 | |
| Kynam Capital Management, LP | 3.11M | no change | Aug 14, 2026 | |
| Rtw Investments, LP | 2.36M | +658K | Aug 14, 2026 | |
| Siren, L.L.C. | 1.89M | +700K | Aug 13, 2026 |